Return On Assets of CytomX Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CytomX Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • CytomX Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was 20%, a 151% increase year-over-year.
  • CytomX Therapeutics, Inc. annual Return On Assets for 2024 was 21%.
  • CytomX Therapeutics, Inc. annual Return On Assets for 2023 was -0.26%, a 99% increase from 2022.
  • CytomX Therapeutics, Inc. annual Return On Assets for 2022 was -38%, a 27% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

CytomX Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 20% +12% +151% 01 Jul 2025 30 Sep 2025
Q2 2025 36% +30% +523% 01 Apr 2025 30 Jun 2025
Q1 2025 32% +24% +297% 01 Jan 2025 31 Mar 2025
Q4 2024 21% +21% 01 Oct 2024 31 Dec 2024
Q3 2024 8.1% +12% 01 Jul 2024 30 Sep 2024
Q2 2024 5.8% +24% 01 Apr 2024 30 Jun 2024
Q1 2024 8.1% +37% 01 Jan 2024 31 Mar 2024
Q4 2023 -0.26% +38% +99% 01 Oct 2023 31 Dec 2023
Q3 2023 -4.4% +40% +90% 01 Jul 2023 30 Sep 2023
Q2 2023 -18% +22% +55% 01 Apr 2023 30 Jun 2023
Q1 2023 -29% +6.6% +19% 01 Jan 2023 31 Mar 2023
Q4 2022 -38% -8.1% -27% 01 Oct 2022 31 Dec 2022
Q3 2022 -45% -18% -67% 01 Jul 2022 30 Sep 2022
Q2 2022 -40% -15% -59% 01 Apr 2022 30 Jun 2022
Q1 2022 -35% -10% -42% 01 Jan 2022 31 Mar 2022
Q4 2021 -30% -13% -82% 01 Oct 2021 31 Dec 2021
Q3 2021 -27% -7.2% -37% 01 Jul 2021 30 Sep 2021
Q2 2021 -25% -5.9% -31% 01 Apr 2021 30 Jun 2021
Q1 2021 -25% -4.7% -23% 01 Jan 2021 31 Mar 2021
Q4 2020 -16% +9.7% +37% 01 Oct 2020 31 Dec 2020
Q3 2020 -20% +4% +17% 01 Jul 2020 30 Sep 2020
Q2 2020 -19% +2.8% +13% 01 Apr 2020 30 Jun 2020
Q1 2020 -20% -1.3% -6.9% 01 Jan 2020 31 Mar 2020
Q4 2019 -26% -6.2% -31% 01 Oct 2019 31 Dec 2019
Q3 2019 -24% -11% -86% 01 Jul 2019 30 Sep 2019
Q2 2019 -22% -12% -120% 01 Apr 2019 30 Jun 2019
Q1 2019 -19% -5.6% -42% 01 Jan 2019 31 Mar 2019
Q4 2018 -20% -6.9% -52% 01 Oct 2018 31 Dec 2018
Q3 2018 -13% +8% +39% 01 Jul 2018 30 Sep 2018
Q2 2018 -10% +17% +63% 01 Apr 2018 30 Jun 2018
Q1 2018 -13% +13% +49% 01 Jan 2018 31 Mar 2018
Q4 2017 -13% +17% +56% 01 Oct 2017 31 Dec 2017
Q3 2017 -21% +7.9% +28% 01 Jul 2017 30 Sep 2017
Q2 2017 -27% +2.8% +9.3% 01 Apr 2017 30 Jun 2017
Q1 2017 -26% 01 Jan 2017 31 Mar 2017
Q4 2016 -30% 01 Oct 2016 31 Dec 2016
Q3 2016 -29% 01 Jul 2016 30 Sep 2016
Q2 2016 -30% 01 Apr 2016 30 Jun 2016

CytomX Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 21% +21% 01 Jan 2024 31 Dec 2024
2023 -0.26% +38% +99% 01 Jan 2023 31 Dec 2023
2022 -38% -8.1% -27% 01 Jan 2022 31 Dec 2022
2021 -30% -13% -82% 01 Jan 2021 31 Dec 2021
2020 -16% +18% +52% 01 Jan 2020 31 Dec 2020
2019 -34% -14% -70% 01 Jan 2019 31 Dec 2019
2018 -20% -6.9% -52% 01 Jan 2018 31 Dec 2018
2017 -13% +17% +56% 01 Jan 2017 31 Dec 2017
2016 -30% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.